Prof. Dr. Neslihan CABIOĞLU

Yayın Ağı

Makaleler 152

1. Long-term outcomes of Türkiye's first population-based mammography screening program: a decade of breast cancer detection and survival analysis in Bahçeşehir

ÖZÇINAR B., ARIBAL M. E., Cabioglu N., Gurdal S. O., Varol G., AKYURT N., et al.

BMC WOMENS HEALTH , cilt.25, sa.1, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

2. Air-Assisted Mastectomy Using LigaSure for a Breast Cancer Patient With a Cardiac Pacemaker

Tukenmez M., Mollavelioglu B., Emiroglu S., Cabioglu N., Muslumanoglu M., Ozmen V.

European Journal of Breast Health , cilt.21, sa.4, ss.384-386, 2025 (ESCI)

3. Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a

Soran A., Göktepe B., Demirors B., Aytac O., Ozbas S., Dogan L., et al.

Current Oncology , cilt.32, sa.10, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

4. Comparison of tumor clipping and marking of skin projection methods in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy: A randomized controlled trial

Kut A., EMİROĞLU S., CABIOĞLU N., Muslumanoglu M., Yilmaz R. S., Bozdogan A., et al.

MEDICINE , cilt.104, sa.36, 2025 (SCI-Expanded)

5. Idiopathic Granulomatous Mastitis: A Consensus Report on Treatment and Follow-Up Approaches Based on the Turkish Clinical Classification

Emiroglu M., ÇETİN K., Yilmaz K. B., VELİDEDEOĞLU M., Girgin S., Akcan A., et al.

Breast Care , cilt.20, sa.4, ss.248-255, 2025 (SCI-Expanded)

6. World health Organization's guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoring

Quiambao A., Malekpour M., Golestani A., Heidari-Foroozan M., Ghamari S., Abbasi-Kangevari M., et al.

eClinicalMedicine , cilt.85, 2025 (SCI-Expanded)

7. Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study

Cabıoğlu N., KARANLIK H., Özmen V., Tükenmez M., İğci A., Aytin Y. E., et al.

Clinical Breast Cancer , cilt.25, sa.5, ss.455-463, 2025 (SCI-Expanded, Scopus)

8. Changing practice patterns in axillary management for patients with node-positive breast cancer towards increased use of sentinel lymph node biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons.

Cabıoğlu N., Ercan D. O., Karataş İ., Eröz E., Toprak S., Emiroğlu S., et al.

Langenbeck's archives of surgery , cilt.410, sa.1, ss.196, 2025 (SCI-Expanded)

9. Role of Lymphoscintigraphy in Repeat Sentinel Lymph Node Biopsy for cN0 Ipsilateral Breast Cancer Recurrence.

Dinçer B., Has Şimşek D., Emiroğlu S., Tükenmez M., Müslümanoğlu M., Cabıoğlu N.

Molecular imaging and radionuclide therapy , cilt.34, sa.2, ss.122-128, 2025 (ESCI) Sürdürülebilir Kalkınma

10. Comparison of Clinicopathologic Features and Survival Outcomes of Pleomorphic Lobular, Classical Lobular, and Invasive Ductal Carcinoma

Sanli A. N., KARA H., Tekcan Sanli D. E., ARIKAN A. E., Cabioglu N., URAS C.

World Journal of Surgery , cilt.49, sa.6, ss.1406-1417, 2025 (SCI-Expanded)

11. De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer

CABIOĞLU N., Kocer H. B., KARANLIK H., Guelcelik M. A., Igci A., Muesluemanoglu M., et al.

JAMA SURGERY , cilt.160, sa.3, ss.257-266, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i1): The OPBC-05/ICARO Study

Montagna G., Laws A., Ferrucci M., Mrdutt M. M., Sun S. X., BADEMLER S., et al.

Journal of Clinical Oncology , cilt.43, sa.7, ss.810-820, 2025 (SCI-Expanded, Scopus)

13. ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03

CABIOĞLU N., KARANLIK H., Igci A., Muslumanoglu M., Gulcelik M. A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

14. ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is Administered

Cabioglu N., KARANLIK H., Igci A., Muslumanoglu M., Gulcelik M. A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.32, sa.2, ss.971-972, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03

Cabioglu N., Karanlık H., Igci A., Muslumanoglu M., Gulcelik M. A., Uras C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.32, sa.2, ss.952-966, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Estrogen receptor positivity in stromal cells of the tumor bed predicts the response to neoadjuvant chemotherapy for breast carcinoma

BAYRAM A., Bagbudar S., KARANLIK H., CABIOĞLU N., AYDINER A., ÖNDER S., et al.

BREAST CANCER RESEARCH AND TREATMENT , 2025 (SCI-Expanded)

17. Evaluating the efficacy of preoperative radiotherapy in breast cancer patients non-responsive to neoadjuvant chemotherapy: A clinical trial

Muslumanoglu M., Ozkurt E., EMİROĞLU S., İBİŞ K., Abuaisha A., TÜKENMEZ M., et al.

BIOMEDICAL RESEARCH AND THERAPY , sa.12, ss.6978-6988, 2025 (ESCI)

18. Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided

Muslumanoglu M., Cabioglu N., Igci A., Karanlık H., Kocer H. B., Senol K., et al.

CANCER , cilt.131, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy

Muslumanoglu M., Mollavelioglu B., Cabioglu N., Emiroglu S., Tukenmez M., Karanlık H., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.22, sa.1, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

20. Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy

Cabıoğlu N., KARANLIK H., Yılmaz R. S., Emiroğlu S., Tükenmez M., BADEMLER S., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.22, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Diagnosis, Approach, and Clinical Classification of Idiopathic Granulomatous Mastitis: Consensus Report

Emiroglu M., Akcan A., VELİDEDEOĞLU M., Girgin S., Aytac O., CANTÜRK N. Z., et al.

Breast Care , cilt.19, sa.5, ss.243-251, 2024 (SCI-Expanded)

22. Diagnostic capabilities of artificial intelligence as an additional reader in a breast cancer screening program

Seker M. E., Koyluoglu Y. O., ÖZAYDIN A. N., Gurdal S. O., ÖZÇINAR B., Cabioglu N., et al.

EUROPEAN RADIOLOGY , cilt.34, sa.9, ss.6145-6157, 2024 (SCI-Expanded)

23. New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer

Cabioglu N., Onder S., Karatay H., Bayram A., Oner G., Tukenmez M., et al.

Cancers , cilt.16, sa.13, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

24. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

Montagna G., Mrdutt M. M., Sun S. X., Hlavin C., Diego E. J., Wong S. M., et al.

JAMA Oncology , cilt.10, sa.6, ss.793-798, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

25. MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET).

Banys-Paluchowski M., Kuehn T., Masannat Y., Ditsch N., Cabıoğlu N., Harvey J., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.42, sa.16_suppl, ss.67-68, 2024 (Scopus)

26. A Novel Surgical Technique for Gynecomastia: Air-Assisted Minimally Invasive Surgery With Single Axillary Incision

Tukenmez M., Mollavelioglu B., Kozanoglu E., Emiroglu S., Cabioglu N., Muslumanoglu M.

SURGICAL INNOVATION , cilt.31, sa.1, ss.5-10, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

27. The Effect of Adjuvant Therapies for Recurrence in Stage I Breast Cancer Patients: A Single Centre Experience

Doğan İ., Khanmammadov N., Aydin E., PAKSOY N., Ferhatoğlu F., AK N., et al.

Turk Onkoloji Dergisi , cilt.39, sa.3, ss.257-264, 2024 (ESCI, Scopus, TRDizin)

28. Evaluation of immune density, PD-L1, and CXCR4 expressions in metaplastic breast carcinoma to predict potential immunotherapy benefit.

Bagbudar S., KARANLIK H., Cabioglu N., Bayram A., Tükenmez M., AYDINER A., et al.

Medical oncology (Northwood, London, England) , cilt.41, sa.1, ss.18, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

29. Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients

DOĞAN İ., Aydin E., KHANMAMMADOV N., Paksoy N., Ferhatoğlu F., AK N., et al.

Journal of Cancer Research and Clinical Oncology , cilt.149, sa.16, ss.14833-14841, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Pregnancy-associated breast malignancy mostly presents with an aggressive type of breast cancer

ACAR İ., Ercan L. D., EMİROĞLU S., TÜKENMEZ M., EMİROĞLU B., Muslumanoglu M., et al.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , sa.5, ss.1-10, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

31. Effect of Cold Therapy on Managing Postoperative Pain Following Breast Conserving Surgery

Emiroglu S., Esen E., Yalcin N., Azizoglu F. S., Zent N., Bozdogan A., et al.

PAIN MANAGEMENT NURSING , cilt.24, sa.4, ss.452-455, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Evaluation of Benign Breast Diseases with or without Atypical Epithelial Hyperplasia Accompanying Radial Scars

Turkyilmaz Z., Sarisik E., Ozkurt E., Tukenmez M., Emiroglu S., Emiroglu B., et al.

European Journal of Breast Health , cilt.19, sa.2, ss.166-171, 2023 (Scopus)

33. Pure Tubular Breast Carcinoma: Clinicopathological Characteristics and Clinical Outcomes

Emiroglu S., Abuaisha A. M., Tukenmez M., Cabioglu N., Bayram A., Ozmen V., et al.

European Journal of Breast Health , cilt.19, sa.2, ss.115-120, 2023 (Scopus)

34. Single axillary incision endoscopic surgery and liposuction for gynecomastia

Tukenmez M., Emiroglu S., Kozanoglu E., Akalin B. E., Mollavelioglu B., Cabioglu N., et al.

Medicine (United States) , cilt.102, sa.7, 2023 (SCI-Expanded)

35. Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)

Banys-Paluchowski M., Kühn T., Masannat Y., Rubio I., de Boniface J., Ditsch N., et al.

Cancers , cilt.15, sa.4, 2023 (SCI-Expanded)

36. Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

CABIOĞLU N., BAYRAM A., EMİROĞLU S., ÖNDER S., Karatay H., Oner G., et al.

FRONTIERS IN ONCOLOGY , cilt.13, 2023 (SCI-Expanded)

37. Surgery for phyllodes tumour of the breast. What should be surgical margins?

Tukenmez M., Mollavelioglu B., Onder S., Emiroglu S., VELİDEDEOĞLU M., ERGÜN S., et al.

ANZ Journal of Surgery , cilt.93, sa.1-2, ss.257-262, 2023 (SCI-Expanded)

38. Ozone therapy restores immune dysfunction in refractory idiopathic granulomatous mastitis as a novel potential therapeutic approach

Cabioglu N., Aktas E., Emiroglu S., Tukenmez M., Ozkurt E., Muslumanoglu M., et al.

CELL BIOLOGY INTERNATIONAL , cilt.47, sa.1, ss.228-237, 2023 (SCI-Expanded)

39. Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitis

Cabioglu N., Trabulus D. C., Emiroglu S., Ozkurt E., Yalcin N., Dinc N., et al.

Frontiers in Medicine , cilt.10, 2023 (SCI-Expanded)

40. Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacy

Cabioglu N., URAS C., Mutlu H., Sezgin D., Emiroglu S., DÜLGEROĞLU O., et al.

Frontiers in Medicine , cilt.10, 2023 (SCI-Expanded)

41. Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?

Emiroglu S., Özkurt E., Cabıoglu N., Igci A., Saip P., YAZICI H., et al.

Breast Cancer: Targets and Therapy , cilt.15, ss.163-173, 2023 (SCI-Expanded)

42. Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes

Özkurt E., Emiroğlu S., Cabioğlu N., Karanlık H., Önder S., Tükenmez M., et al.

BREAST CARE , cilt.17, sa.6, ss.554-560, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

43. Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up

URAS C., Cabioglu N., TOKAT F., ER O., KARA H., KORKMAZ T., et al.

BMC Cancer , cilt.22, sa.1, 2022 (SCI-Expanded)

44. SPECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast Cancer

Has Simsek D., Emiroglu S., Yilmaz R. S., Bayram A., Isik E. G., Tukenmez M., et al.

CLINICAL NUCLEAR MEDICINE , cilt.47, sa.11, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

45. High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer

MOLLAVELİOĞLU B., ÇETİN E., CABIOĞLU N., Abbasov A., ÖNDER S., EMİROĞLU S., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.20, sa.1, 2022 (SCI-Expanded)

46. Can We Predict Triple Negative Breast Cancer with Magnetic Resonance Imaging Findings?

CİNGÖZ E., CÖMERT R. G., BAYRAMOĞLU Z., CABIOĞLU N., Yılmaz S. R.

Current Research in MRI , cilt.1, sa.2, ss.33-37, 2022 (Hakemli Dergi)

47. Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical Outcomes

EMİROĞLU S., Tukenmez M., Karakus S., KARANLIK H., Onder S., Ozmen V., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.18, sa.4, ss.353-359, 2022 (ESCI)

48. Abbreviated and Standard Breast MRI in Neoadjuvant Chemotherapy Response Evaluation: A Comparative Study

Yirgin İ., Engin G., Yildiz Ş., Aydin E. C., Karanlik H., Cabioglu N., et al.

CURRENT MEDICAL IMAGING , cilt.18, sa.10, ss.1052-1060, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

49. The Contribution of ¹⁸F-FES PET/CT in Therapy Management of Estrogen Receptor Positive Breast Cancer

Oflas M., Simsek D. H., Isik E., Cabioglu N., Ibis K., Aydiner A., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , sa.SUPPL 1, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

50. Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?

Cabioglu N., Karanlik H., Igci A., Muslumanoglu M., Tukenmez M., Emiroglu S., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.310-311, 2022 (SCI-Expanded, Scopus)

51. Sentinel lymph node biopsy with/without axillary dissection in clinically node-positive breast cancer after neoadjuvant chemotherapy

Cabioglu N., Karanlik H., Gulcelik M. A., Ilgun S., Igci A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.69-70, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

52. Topografic localisation is enough for correct excision following neoadjuvant chemotherapy in nonpalpable breast cancer

Muslumanoglu M., Emiroglu S., Mollavelioglu B., Atalay B., Yanik M., Yilmaz R., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.171, 2022 (SCI-Expanded)

53. The American Society of Breast Surgeons Official Proceedings, Volume XXIII 2022 Annual Meeting Scientific Session Abstracts

Müslümanoğlu M., Özkurt S., Emiroğlu S., Özkurt E., Küçücük S., Tükenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.S1, ss.288, 2022 (SCI-Expanded)

54. Efficacy of preoperative radiotherapy for non-responder breast cancer patients following to neoadjuvant chemotherapy

Muslumanoglu M., Emiroglu S., Ozkurt E., Ozkurt S., Kucucuk S., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.288, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

55. Prognostic Implications of Immune Infiltrates in the Breast Cancer Microenvironment: The Role of Expressions of CTLA-4, PD-1, and LAG-3

Bagbudar S., Karanlik H., Cabioglu N., Bayram A., Ibis K., Aydin E., et al.

Applied Immunohistochemistry and Molecular Morphology , cilt.30, sa.2, ss.99-107, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

56. Poor Outcome in Pregnancy-associated Breast Cancer among Turkish Women:An aggressive type of breast carcinoma

Acar I., Yıldırım D. O., Emiroğlu S., Tükenmez M., Müslümanoğlu M., İğci A., et al.

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY , cilt.48, sa.2, ss.57, 2022 (Scopus)

57. Diagnostic Performance of AI for Cancers Registered in A Mammography Screening Program: A Retrospective Analysis

KIZILDAĞ YIRGIN İ., Koyluoglu Y. O., Seker M. E., Ozkan Gurdal S., ÖZAYDIN A. N., Ozcinar B., et al.

Technology in Cancer Research and Treatment , cilt.21, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

58. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study

Cabıoğlu N., Karanlık H., Yıldırım N., Müslümanoğlu M., Çakmak Karadeniz G., Trabulus Can D., et al.

EJSO , sa.10, ss.2506-2514, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment

Karanlik H., CABIOĞLU N., Oprea A. L., ÖZGÜR İ., AK N., AYDINER A., et al.

BREAST CARE , cilt.16, sa.5, ss.468-474, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

60. The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study

Soran A., Dogan L., Isik A., Ozbas S., Trabulus D. C., Demirci U., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, sa.9, ss.5048-5057, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

61. Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

Oner G., Onder S., Karatay H., Ak N., Tukenmez M., Muslumanoglu M., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.19, sa.1, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

62. NEUROENDOCRINE CARCINOMA OF THE BREAST: 18 CASES WITH LONG-TERM FOLLOW-UP

Ozkurt E., İLHAN M., Cucuk O. C., TÜKENMEZ M., CABIOĞLU N., Muslumanoglu M.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.84, sa.4, ss.521-525, 2021 (ESCI)

63. The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01Q

Soran A., Soyder A., Ozbas S., Ozmen V., Karanlik H., Igci A., et al.

SUPPORTIVE CARE IN CANCER , cilt.29, sa.7, ss.3823-3830, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

64. Long-term outcomes and predictors of recurrence in patients with early-stage node negative breast cancer.

Dogan I., Aydin E., Paksoy N., Ferhatoglu F., Ak N., Ibis K., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.15, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

65. Ozone Therapy as a Novel Potential Approach in Patients with Severe Granulomatous Mastitis Is Associated with an Improved T-helper-1 Response

Cabioglu N., Aktas E., Emiroglu S., Tukenmez M., Dinc N., Muslumanoglu M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, 2021 (SCI-Expanded)

66. Is There Any Advantage of Targeted Axillary Dissection After Neoadjuvant Chemotherapy in Patients with Initially Positive Clipped Node?

Cabioglu N., Karanlik H., Yilmaz R., Emiroglu S., Dursun M., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, sa.SUPPL 2, 2021 (SCI-Expanded)

67. Is Sentinel Lymph Node Biopsy with Radiotherapy Alone Safe in Clinically Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?: Turkish Multicentric Neosentiturk-Trial/MF-18-03

Cabioglu N., Karanlik H., Muslumanoglu M., Ozmen V., Karadeniz G., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, sa.SUPPL 2, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

68. Efficacy of Ozone Therapy as a Novel Potential Therapeutic Approach in Severe Granulomatous Mastitis

Cabioglu N., Trablus D. C., Yalcin N., Emiroglu S., Dinc N., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, 2021 (SCI-Expanded)

69. The effect of primary surgery in patients with stage IV breast cancer with bone metastasis only (protocol bomet MF14-01); a multi-center, registry study

Soran A., Dogan L., Ozbas S., Isik A., Trablus D., Demirci U., et al.

BREAST , cilt.56, 2021 (SCI-Expanded)

70. TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer

Cabioglu N., Onder S., Oner G., Karatay H., Tukenmez M., Muslumanoglu M., et al.

BMC CANCER , cilt.21, sa.1, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

71. Bahcesehir long-term population-based screening compared to National Breast Cancer Registry Data: effectiveness of screening in an emerging country

Gurdal S. O., Özaydın A. N., Arıbal M. E., Özçınar B., Cabıoğlu N., Sahin C., et al.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , cilt.27, sa.2, ss.157-163, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

72. Abstract PS4-32: Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer

Cabioglu N., Onder S., Oner G., Karatay H., Tukenmez M., Muslumanoglu M., et al.

CANCER RESEARCH , cilt.81, sa.4_Supplement, ss.32, 2021 (Scopus)

73. Sentinel lymph node biopsy alone in locally advanced breast cancer after neoadjuvant chemotherapy: Turkish multicentric neosenti-turk MF-18-02-study

Cabioglu N., Karanlik H., Muslumanoglu M., Cakmak G. K., Trablus D. C., Tukenmez M., et al.

CANCER RESEARCH , cilt.81, sa.4, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer

Cabioglu N., Onder S., Oner G., Karatay H., Tukenmez M., Muslumanoglu M., et al.

CANCER RESEARCH , cilt.81, sa.4, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

75. Differential expression of novel immune checkpoint receptors on tumor-infiltrating lymphocytes in patients with locally advanced breast cancer after neoadjuvant chemotherapy

Abbasov A., Aktas Cetin E., Cabioglu N., Mollavelioglu B., Onder S., Emiroglu S., et al.

NEOPLASMA , sa.5, ss.1079-1090, 2021 (SCI-Expanded)

76. Effect of Astragalus Membranaceus on Patients with Metastatic Non-Small Cell Lung Cancer: A Retrospective Cohort Study

Ak N., Ciftci R., Cabioglu N., Aydiner A.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.36, sa.2, ss.215-221, 2021 (ESCI) Sürdürülebilir Kalkınma

77. Differential expressions of immune check point receptors on tumor infiltrating lymphocytes after neo-adjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC)

Abbasov A., ÇETİN E., CABIOĞLU N., MOLLAVELİOĞLU B., ÖNDER S., EMİROĞLU S., et al.

CANCER RESEARCH , cilt.80, sa.16, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

78. Poor Biological Factors and Prognosis of Interval Breast Cancers: Long-Term Results of Bahceehir (Istanbul) Breast Cancer Screening Project in Turkey

CABIOĞLU N., ÖZKAN GÜRDAL S., Kayhan A., OEzaydin N., Sahin C., Can O., et al.

JCO GLOBAL ONCOLOGY , cilt.6, ss.1103-1113, 2020 (ESCI) Sürdürülebilir Kalkınma

79. Comparison of Qualitative and Volumetric Assessments of Breast Density and Analyses of Breast Compression Parameters and Breast Volume of Women in Bahcesehir Mammography Screening Project

Gemici A. A., ARIBAL M. E., ÖZAYDIN A. N., ÖZKAN GÜRDAL S., Ozcinar B., CABIOĞLU N., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.16, sa.2, ss.110-116, 2020 (ESCI) Sürdürülebilir Kalkınma

80. Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer

Kizildag Yirgin İ., Has D., Arslan G., Aydin E. C., Sari M., Onder S., et al.

EUROPEAN JOURNAL OF RADIOLOGY OPEN , cilt.7, 2020 (ESCI) Sürdürülebilir Kalkınma

81. Our 20-Year Institutional Experience with Surgical Approach for Breast Hamartomas

Turkyilmaz Z., Aydin T., Yilmaz R. S., Onder S., Ozkurt E., Tukenmez M., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.15, ss.171-175, 2019 (ESCI)

82. "Hidradenoma of the breast: Magnetic resonance (MR) imaging and ultrasonography (US) findings of this rare mass".

Yılmaz R. S., Tuncer S., Önder S., Cabıoğlu N., Acunas G.

The breast journal , cilt.25, ss.314-315, 2019 (SCI-Expanded)

83. Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy

Cabioglu N., Onder S., Oner G., Karatay H., Ozkurt E., Trablus D. C., et al.

BREAST , cilt.44, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

84. Methylation Changes of Primary Tumors, Monolayer, and Spheroid Tissue Culture Environments in Malignant Melanoma and Breast Carcinoma

Erdogan O. S., Erciyas S., Bilir A., Tuncer S. B., Odemis D. A., Kurul S., et al.

BIOMED RESEARCH INTERNATIONAL , cilt.2019, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

85. Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer

Ozkurt E., Yardımcı E., Tukenmez M., Ersoy Y. E., Yilmaz R. S., Cabioglu N., et al.

BREAST JOURNAL , cilt.25, ss.96-102, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

86. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01

Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.25, ss.3141-3149, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

87. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.

Cabıoğlu N., Karanlık H., Kangal D., Ozkurt E., Öner G., Sezen F., et al.

Annals of surgical oncology , cilt.25, ss.3030-3036, 2018 (SCI-Expanded)

88. Favorable Long-Term Outcome in Male Breast Cancer

Ozkurt E., Tukenmez M., Yilmaz R. S., Cabioglu N., Muslumanoglu M., Dinccag A. S., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.14, ss.180-185, 2018 (ESCI) Sürdürülebilir Kalkınma

89. High expression of pdl-1 in patients with triple negative breast cancer with residual tumor burden after neoadjuvant chemotherapy.

Oner G., Önder S., Karatay H., Tükenmez M., Muslumanoglu M., Igci A., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.36, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

90. Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up

Ozkurt E., Tukenmez M., Guven E., Ozden B. C., Oner G., Muslumanoglu M., et al.

BALKAN MEDICAL JOURNAL , cilt.35, ss.84-92, 2018 (SCI-Expanded)

91. Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis

Onder S., Fayda M., Karanlik H., Bayram A., Sen F., Cabioglu N., et al.

BREAST JOURNAL , cilt.23, sa.6, ss.638-646, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

92. Cost-Effectiveness of Breast Cancer Screening in Turkey, a Developing Country: Results from Bahcesehir Mammography Screening Project

Ozmen V., Özkan Gürdal S., Cabioglu N., Ozcinar B., Ozaydin A. N., Kayhan A., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.13, ss.117-125, 2017 (ESCI) Sürdürülebilir Kalkınma

93. Radiologic findings of screen-detected cancers in an organized population-based screening mammography program in Turkey

Kayhan A., Aribal E., Sahin C., Tasci O. C., Özkan Gürdal S., Ozturk E., et al.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , cilt.22, ss.508-513, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

94. Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey

Ozmen V., Atasoy A., Gökmen E., Ozdogan M., Guler N., Uras C., et al.

JOURNAL OF BREAST HEALTH , cilt.12, ss.107-111, 2016 (ESCI) Sürdürülebilir Kalkınma

95. Perforated double appendicitis: Horseshoe type

Bulut S. P., Cabioglu N., Akinci M.

TURKISH JOURNAL OF SURGERY , cilt.32, sa.2, ss.134-136, 2016 (ESCI)

96. Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome

Karanlik H., Özgür I., Cabioglu N., Sen F., Erturk K., Kilic B., et al.

EJSO , cilt.41, sa.9, ss.1226-1233, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

97. The Use of Ligasure Vessel Sealing System in Axillary Dissection; Effect on Seroma Formation

Tükenmez M., Agcaoglu O., Aksakal N., Destek S., Cabıoğlu N., Barbaros U., et al.

CHIRURGIA , cilt.109, ss.620-625, 2014 (ESCI)

98. Factors Predicting Microinvasion in Ductal Carcinoma in situ

Ozkan-Gurdal S., Cabioglu N., Ozcinar B., Muslumanoglu M., Ozmen V., Kecer M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, ss.55-60, 2014 (SCI-Expanded)

99. Successful First Round Results of a Turkish Breast Cancer Screening Program with Mammography in Bahcesehir, Istanbul

Kayhan A., Gurdal S. O., Ozaydin N., Cabioglu N., Ozturk E., Ozcinar B., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, ss.1693-1697, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

100. Successful results of a population-based organized mammography screening program in a developing country: The Turkish experience

OZMEN V., OZKAN-GURDAL S., KAYHAN A., OZAYDIN N., CABIOGLU N., Ozcinar B., et al.

CANCER RESEARCH , cilt.73, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

101. Early follow up of a randomized trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer; Turkish study (protocol MF07-01)

Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., et al.

CANCER RESEARCH , cilt.73, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

102. Young-onset breast cancer exhibits a more aggressive tumor biology

CABIOĞLU N., Bozdogan A., Eren-Boler D., Kara H., Karayagiz H., Uras C.

CANCER RESEARCH , cilt.73, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

103. Molecular profiles of screen detected breast cancers: Final results of Turkish Bahcesehir breast cancer screening project

Cabioglu N., Ozkan-Gurdal S., Kayhan A., Ozaydin N., Ozcinar B., Aribal E., et al.

CANCER RESEARCH , cilt.73, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

104. FIRST ROUND RESULTS OF A LONG TERM POPULATION- BASED BREAST CANCER SCREENING PROGRAM FROM BAHCESEHIR

Kayhan A., Gurdal S. O., ÖZAYDIN A. N., Ozturk E., CABIOĞLU N., ARIBAL M. E., et al.

JOURNAL OF BREAST HEALTH , cilt.8, sa.4, ss.180-184, 2012 (ESCI) Sürdürülebilir Kalkınma

105. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases

Boler D. E., URAS C., İNCE Ü., CABIOĞLU N.

BREAST , cilt.21, sa.4, ss.518-523, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

106. Positive or close margins in breast conserving surgery: Is re-excision always necessary?

Gurdal S. O., Karanlik H., Cabioglu N., Ozcinar B., Yavuz E., Tuzlali S., et al.

EJSO , cilt.38, sa.5, ss.399-406, 2012 (SCI-Expanded)

107. Comparison of Intermittent Pneumatic Compression with Manual Lymphatic Drainage for Treatment of Breast Cancer-Related Lymphedema

Gurdal S. O., Kostanoglu A., Cavdar I., Ozbas A., Cabioglu N., Ozcinar B., et al.

LYMPHATIC RESEARCH AND BIOLOGY , cilt.10, sa.3, ss.129-135, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

108. Successfully treated Mycobacterium abscessus mastitis: A rare cause of breast masses

Yasar K. K., Pehlivanoglu F., Sengoz G., CABIOĞLU N.

INDIAN JOURNAL OF MEDICAL MICROBIOLOGY , cilt.29, sa.4, ss.425-427, 2011 (SCI-Expanded)

109. Survey on a Mammographic Screening Program in Istanbul, Turkey

Ozmen V., ÖZAYDIN A. N., Cabioglu N., Gulluoglu B. M., Unalan P. C., Gorpe S., et al.

BREAST JOURNAL , cilt.17, sa.3, ss.260-267, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

110. A Randomized Trial Comparing Intermittent Pneumatic Compression with Manual Lymphatic Drainage for Treatment of Lymphedema in Patients with Breast Cancer

Gurdal S. O., KOSTANOGLU A., CAVDAR I., OZBAS A., CABIOGLU N., Ozcinar B., et al.

CANCER RESEARCH , cilt.70, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

111. Appendicitis with Atypical Location Owing to Malrotation: A Case Report

Ozer E., Kocakusak A., Avsar U., Akinci M., CABIOĞLU N.

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI , cilt.48, sa.2, ss.89-91, 2010 (ESCI)

112. BREAST CANCER KNOWLEDGE, SOURCE OF INFORMATION, AND BREAST HEALTH PRACTICES OF WOMEN IN BAHCESEHIR

ÖZAYDIN A. N., GÜLLÜOĞLU M. B., Unalan P. C., Gorpe S., CABIOĞLU N., Oner B. R., et al.

JOURNAL OF BREAST HEALTH , cilt.5, sa.4, ss.214-224, 2009 (ESCI) Sürdürülebilir Kalkınma

113. Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications

CABIOĞLU N., Sahin A. A., Morandi P., Meric-Bernstam F., Islam R., Lin H. Y., et al.

ANNALS OF ONCOLOGY , cilt.20, sa.6, ss.1013-1019, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

114. Breast cancer risk factors in Turkish women - a University Hospital based nested case control study

Ozmen V., Ozcinar B., Karanlik H., Cabioglu N., Tukenmez M., Disci R., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.7, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

115. Increased Lymph Node Positivity in Multifocal and Multicentric Breast Cancer

Cabioglu N., Ozmen V., Kaya H., Tuzlali S., Igci A., Muslumanoglu M., et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS , cilt.208, sa.1, ss.67-74, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

116. Immune changes in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy

Cabioǧlu N., Müslümanoǧlu M. E., Tütüncü Y., Adin-Cinar S., Gürel N., KIRAN B., et al.

Turkish Journal of Immunology , cilt.13, sa.1, ss.15-20, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

117. Guideline Implementation for Breast Healthcare in Low- and Middle-income Countries Early Detection Resource Allocation

Yip C., Smith R. A., Anderson B. O., Miller A. B., Thomas D. B., Ang E., et al.

CANCER , cilt.113, ss.2244-2256, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

118. Detection of bone marrow micrometastases by reverse-transcriptase polymerase chain reaction (RT-PCR) in patients with early breast cancer Erken evre meme kanserinde revers transkriptaz polimeraz zincir reaksiyonu (RT-PCR) tekniǧi ile kemik iliǧi mikrometastazlarinin araştirilmasi

Cabioǧlu N., Yildirim E. O., Bitişik Ö., Yazici H., Müslümanoǧlu M., Dalay N., et al.

Turk Onkoloji Dergisi , cilt.23, sa.2, ss.55-62, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

119. Immune changes in patients with locally advenced breast cancer receiving neoadjuvant chemotherapy.

CABIOĞLU N., MÜSLÜMANOĞLU M. E., Tütüncü Y., ÇINAR S., Gürel N., Kıran B., et al.

Türk İmmünoloji Dergisi , cilt.13, ss.15-20, 2008 (Hakemli Dergi) Sürdürülebilir Kalkınma

120. TREATMENT MODALITIES OF PHYLLODES TUMORS OF THE BREAST

CABIOĞLU N., Celik T., ÖZMEN V., Igci A., Muslumanoglu M., ÖZÇINAR B., et al.

JOURNAL OF BREAST HEALTH , cilt.4, sa.2, ss.99-104, 2008 (ESCI)

121. Erken Evre Meme Kanserinde Revers Transkriptaz Polimeraz Zincir Reaksiyonu Tekniği ile Kemik İliği Mikrometastazlarının Araştırılması

CABİOĞLU N., YILDIRIM O., Bitişik Ö., YAZICI ÖZBEK H., MÜSLÜMANOĞLU M. E., DALAY M. N., et al.

TÜRK ONKOLOJİ DERGİSİ , cilt.23, sa.2, ss.55-62, 2008 (Scopus) Sürdürülebilir Kalkınma

122. Clinical Management of Acute Pancreatitis

CABIOĞLU N., Yanar H.

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI , cilt.46, sa.1, ss.1-14, 2008 (ESCI)

123. Predictive factors for local recurrence after breast conservative surgery following neoadjuvant chemotherapy: our long-term results

CABIOĞLU N., Muslumanoglu M., Igci A., Ozcinar B., Ozmen V., Dagoglu T., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.23, sa.2, ss.81-90, 2008 (ESCI)

124. Is the thymidine labeling index a good prognostic marker in breast cancer?

Sen-Oran E., Ozmen V., Bilir A., Cabioglu N., Muslumanoglu M., Igci A., et al.

World journal of surgical oncology , cilt.5, ss.93, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

125. Manipulating the chemokine-chemokine receptor network to treat cancer

Ruffini P. A., Morandi P., CABIOĞLU N., Altundag K., Cristofanilli M.

CANCER , cilt.109, sa.12, ss.2392-2404, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

126. Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer

CABIOĞLU N., Gong Y., Islam R., Broglio K. R., Sneige N., Sahin A., et al.

ANNALS OF ONCOLOGY , cilt.18, sa.6, ss.1021-1029, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

127. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery

CABIOĞLU N., Hunt K. K., Sahin A. A., Kuerer H. M., Babiera G. V., Singletary S. E., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.14, sa.4, ss.1458-1471, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

128. Primary ovarian cancer presenting with axillary lymph node metastases: A report of two cases

Ozmen V., Asoglu O., Karanlık H., Cabıoglu N., Kecer M., Bakkaloglu H.

ACTA CHIRURGICA BELGICA , cilt.107, ss.75-77, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

129. Fournier's gangrene: Risk factors and strategies for management

Yanar H., Taviloglu K., Ertekin C., Guloglu R., Zorba U., Cabioglu N., et al.

WORLD JOURNAL OF SURGERY , cilt.30, sa.9, ss.1750-1754, 2006 (SCI-Expanded)

130. Sentinel lymph node biopsy for breast cancer: Current controversies

Ozmen V., CABIOGLU N.

BREAST JOURNAL , cilt.12, sa.5, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

131. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer

Andre F., CABIOĞLU N., Assi H., Sabourin J. C., Delaloge S., Sahin A., et al.

ANNALS OF ONCOLOGY , cilt.17, sa.6, ss.945-951, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

132. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer

Ozmen V., KARANLIK H., CABIOGLU N., IGCI A., KECER M., ASOGLU O., et al.

BREAST CANCER RESEARCH AND TREATMENT , cilt.95, sa.1, ss.1-6, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

133. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T-1 breast cancer

CABIOĞLU N., Yazici M., Arun B., Broglio K., Hortobagyi G., Price J., et al.

CLINICAL CANCER RESEARCH , cilt.11, sa.16, ss.5686-5693, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

134. CXCL-12/stromal cell-derived factor-1 alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation

Cabioglu N., Summy J., Miller C., Parikh N., Sahin A., Tuzlali S., et al.

CANCER RESEARCH , cilt.65, sa.15, ss.6493-6497, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

135. Improving local control with breast-conserving therapy - A 27-year single-institution experience

CABIOĞLU N., Hunt K., Buchholz T., Mirza N., Singletary S., Kuerer H., et al.

CANCER , cilt.104, sa.1, ss.20-29, 2005 (SCI-Expanded)

136. Idiopathic necrotizing fasciitis: Risk factors and strategies for management

Taviloglu K., Cabioglu N., Cagatay A., Yanar H., Ertekin C., Baspinar I., et al.

AMERICAN SURGEON , sa.4, ss.315-320, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

137. Feasibility of surgical management in patients with granulomatous mastitis

Asoglu O., Ozmen V., Karanlık H., Tunacı M., Cabıoglu N., Igcı A., et al.

BREAST JOURNAL , cilt.11, ss.108-114, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

138. Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow

CABIOGLU N., SAHIN A., DOUCET M., YAVUZ E., IGCI A., YILDIRIM E., et al.

CLINICAL & EXPERIMENTAL METASTASIS , cilt.22, sa.1, ss.39-46, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

139. SHARK CARTILAGE IMPROVES SURVIVAL IN TUMOR IMPLANTED MICE

Kiran B., Zeybek U., Lama A., Cabioglu N., Deniz G.

ANTICANCER RESEARCH , cilt.24, ss.3536, 2004 (SCI-Expanded)

140. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge

CABIOĞLU N., Krishnamurthy S., Kuerer H., Hunt K., Singletary S., Meric-Bernstam F., et al.

CANCER , cilt.101, sa.3, ss.508-517, 2004 (SCI-Expanded)

141. Thymidine labeling index: Prognostic role in breast cancer

Bilir A., Eralp Y., Cabioglu N., Agizhali B., Camlica H., Aydiner A.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.27, sa.4, ss.400-406, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

142. T-cell lymphoblastic lymphoma presenting with a breast mass

Yumuk P., Aydiner A., Topuz E., Cabioglu N., Dogan O.

LEUKEMIA & LYMPHOMA , cilt.45, sa.4, ss.833-836, 2004 (SCI-Expanded)

143. Inflammatory breast cancer: Results of antracycline-based neoadjuvant chemotherapy

Ozmen V., Cabioglu N., Igci A., Dagoglu T., AYDINER A., Kecer M., et al.

Breast Journal , cilt.9, sa.2, ss.79-85, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

144. Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge

CABIOĞLU N., Hunt K., Singletary S., Stephens T., Marcy S., Meric F., et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS , cilt.196, sa.3, ss.354-364, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

145. Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer

Ozmen V., MUSLUMANOGLU M. E., CABIOGLU N., TUZLALI S., ILHAN R., IGCI A., et al.

BREAST CANCER RESEARCH AND TREATMENT , cilt.76, sa.3, ss.237-244, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma

146. An ultrasensitive tumor enriched flow-cytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancer

Cabioglu V., Igci A., Yildirim E., Aktas E., Bilgic S., Yavuz E., et al.

AMERICAN JOURNAL OF SURGERY , sa.5, ss.414-417, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma

147. Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis.

Cabioglu N., Bilgic S., Deniz G., Aktas E., Seyhun Y., Turna A., et al.

Archives of surgery (Chicago, Ill. : 1960) , cilt.137, sa.9, 2002 (SCI-Expanded, Scopus)

148. Endoscopic sphincterotomy in the management of postoperative biliary fistula

Dolay K., Akcakaya A., Soybir G., Cabioglu N., Muslumanoglu M., Igci A., et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES , cilt.16, sa.6, ss.985-988, 2002 (SCI-Expanded)

149. Endoscopic ligation for patients with active bleeding Mallory-Weiss tears

Gunay K., Cabioglu N., Barbaros U., Taviloglu K., Ertekin C.

SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES , cilt.15, sa.11, ss.1305-1307, 2001 (SCI-Expanded, Scopus)

150. Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome

Ozmen V., CABIOGLU N., DOLAY K., BILIR A., KECER M., AYDINER A., et al.

BREAST CANCER RESEARCH AND TREATMENT , cilt.68, sa.2, ss.147-157, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

151. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients

Yazici H., BITISIK O., AKISIK E., CABIOGLU N., SAIP P. M., MUSLUMANOGLU M. E., et al.

BRITISH JOURNAL OF CANCER , cilt.83, sa.6, ss.737-742, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

152. Alterations in cellular immunity of normal pregnant women: Increased percentages of peripheral large granular lymphocytes during early pregnancy

Akgul C., Cabioglu N., Gurel N., Ibrahimoglu L., Altug T., Deniz G.

Turkish Journal of Immunology , cilt.3, sa.1, ss.31-36, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 103

1. PATIENT REPORTED OUTCOMES AND LYMPHEDEMA IN NODE-POSITIVE BREAST CANCER IN THE EARLY POSTOPERATIVE PERIOD AFTER NEOADJUVANT CHEMOTHERAPY IN THE PROSPECTIVE NEOSENTITURK-trial MF18-03

CABIOĞLU N., GÜL KILIÇ H., Bozdoğan A., Rumisa Kılıç B., USLU Y., EMİROĞLU S., et al.

San Antonio Breast Cancer Symposium, New York, Amerika Birleşik Devletleri, 10 Aralık 2024, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

2. Contribution of 18F-FDG MAMMI-PET Imaging in Breast Cancer Staging

ASLANER K., HAS ŞİMŞEK D., ARSLAN D. F., YILMAZ R., ÖNDER S., CABIOĞLU N., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, (Özet Bildiri)

3. MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET)

Banys-Paluchowski M., Kuehn T., Masannat Y., Ditsch N., Cabioglu N., Harvey J., et al.

Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024, (Özet Bildiri)